BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27222939)

  • 1. Lung cancer screening with low-dose spiral computed tomography: evidence from a pooled analysis of two Italian randomized trials.
    Infante M; Sestini S; Galeone C; Marchianò A; Lutman FR; Angeli E; Calareso G; Pelosi G; Sozzi G; Silva M; Sverzellati N; Cavuto S; La Vecchia C; Santoro A; Alloisio M; Pastorino U
    Eur J Cancer Prev; 2017 Jul; 26(4):324-329. PubMed ID: 27222939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
    Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
    Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.
    Pastorino U; Sverzellati N; Sestini S; Silva M; Sabia F; Boeri M; Cantarutti A; Sozzi G; Corrao G; Marchianò A
    Eur J Cancer; 2019 Sep; 118():142-148. PubMed ID: 31336289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial.
    Infante M; Cavuto S; Lutman FR; Brambilla G; Chiesa G; Ceresoli G; Passera E; Angeli E; Chiarenza M; Aranzulla G; Cariboni U; Errico V; Inzirillo F; Bottoni E; Voulaz E; Alloisio M; Destro A; Roncalli M; Santoro A; Ravasi G;
    Am J Respir Crit Care Med; 2009 Sep; 180(5):445-53. PubMed ID: 19520905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.
    Pastorino U; Silva M; Sestini S; Sabia F; Boeri M; Cantarutti A; Sverzellati N; Sozzi G; Corrao G; Marchianò A
    Ann Oncol; 2019 Jul; 30(7):1162-1169. PubMed ID: 30937431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial.
    Pastorino U; Rossi M; Rosato V; Marchianò A; Sverzellati N; Morosi C; Fabbri A; Galeone C; Negri E; Sozzi G; Pelosi G; La Vecchia C
    Eur J Cancer Prev; 2012 May; 21(3):308-15. PubMed ID: 22465911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of low-dose computed tomography screening on lung cancer mortality among asbestos-exposed workers.
    Barbone F; Barbiero F; Belvedere O; Rosolen V; Giangreco M; Zanin T; Pisa FE; Meduri S; Follador A; Grossi F; Fasola G
    Int J Epidemiol; 2018 Dec; 47(6):1981-1991. PubMed ID: 30325420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.
    National Lung Screening Trial Research Team
    J Thorac Oncol; 2019 Oct; 14(10):1732-1742. PubMed ID: 31260833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers.
    Verri C; Borzi C; Holscher T; Dugo M; Devecchi A; Drake K; Sestini S; Suatoni P; Romeo E; Sozzi G; Pastorino U; Boeri M
    J Thorac Oncol; 2017 Jun; 12(6):922-931. PubMed ID: 28302568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants.
    Pastorino U; Boffi R; Marchianò A; Sestini S; Munarini E; Calareso G; Boeri M; Pelosi G; Sozzi G; Silva M; Sverzellati N; Galeone C; La Vecchia C; Ghirardi A; Corrao G
    J Thorac Oncol; 2016 May; 11(5):693-699. PubMed ID: 26921675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute.
    Gohagan J; Marcus P; Fagerstrom R; Pinsky P; Kramer B; Prorok P;
    Chest; 2004 Jul; 126(1):114-21. PubMed ID: 15249451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical procedures in the DANTE trial, a randomized study of lung cancer early detection with spiral computed tomography: comparative analysis in the screening and control arm.
    Infante M; Chiesa G; Solomon D; Morenghi E; Passera E; Lutman FR; Bottoni E; Cariboni U; Errico V; Voulaz E; Ferraroli G; Testori A; Inzirillo F; Chiarenza M; Roncalli M; Cavuto S; Chiti A; Alloisio M; Ravasi G;
    J Thorac Oncol; 2011 Feb; 6(2):327-35. PubMed ID: 21178639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.
    Wille MM; Dirksen A; Ashraf H; Saghir Z; Bach KS; Brodersen J; Clementsen PF; Hansen H; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thomsen LH; Tønnesen P; Pedersen JH
    Am J Respir Crit Care Med; 2016 Mar; 193(5):542-51. PubMed ID: 26485620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
    Paci E; Puliti D; Lopes Pegna A; Carrozzi L; Picozzi G; Falaschi F; Pistelli F; Aquilini F; Ocello C; Zappa M; Carozzi FM; Mascalchi M;
    Thorax; 2017 Sep; 72(9):825-831. PubMed ID: 28377492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
    Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
    Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.
    Sozzi G; Boeri M; Rossi M; Verri C; Suatoni P; Bravi F; Roz L; Conte D; Grassi M; Sverzellati N; Marchiano A; Negri E; La Vecchia C; Pastorino U
    J Clin Oncol; 2014 Mar; 32(8):768-73. PubMed ID: 24419137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer.
    Gohagan JK; Marcus PM; Fagerstrom RM; Pinsky PF; Kramer BS; Prorok PC; Ascher S; Bailey W; Brewer B; Church T; Engelhard D; Ford M; Fouad M; Freedman M; Gelmann E; Gierada D; Hocking W; Inampudi S; Irons B; Johnson CC; Jones A; Kucera G; Kvale P; Lappe K; Manor W; Moore A; Nath H; Neff S; Oken M; Plunkett M; Price H; Reding D; Riley T; Schwartz M; Spizarny D; Yoffie R; Zylak C;
    Lung Cancer; 2005 Jan; 47(1):9-15. PubMed ID: 15603850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory status and lung function predict mortality in lung cancer screening participants.
    Pastorino U; Morelli D; Marchianò A; Sestini S; Suatoni P; Taverna F; Boeri M; Sozzi G; Cantarutti A; Corrao G
    Eur J Cancer Prev; 2018 Jul; 27(4):289-295. PubMed ID: 28333763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality.
    Prosper AE; Inoue K; Brown K; Bui AAT; Aberle D; Hsu W
    JAMA Netw Open; 2021 Aug; 4(8):e2119629. PubMed ID: 34427681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.